• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 XμCT 和组织学对血管组织中的超顺磁纳米粒子进行可视化。

Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology.

机构信息

Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine, Else Kröner-Fresenius-Stiftung, Waldstr. 1, 91054 Erlangen, Germany.

出版信息

Histochem Cell Biol. 2011 Feb;135(2):153-8. doi: 10.1007/s00418-011-0780-8. Epub 2011 Jan 29.

DOI:10.1007/s00418-011-0780-8
PMID:21279377
Abstract

In order to increase the dose of antineoplastic agents in the tumor area, the concept of magnetic drug targeting (MDT) has been developed. Magnetic nanoparticles consisting of iron oxide and a biocompatible cover layer suspended in an aqueous solution (ferrofluid) serve as carriers for chemotherapeutics being enriched by an external magnetic field after intra-arterial application in desired body compartments (i.e., tumor). We established an ex vivo model to simulate in vivo conditions in a circulating system consisting of magnetic iron oxide nanoparticles passing an intact bovine artery and being focused by an external magnetic field to study their distribution in the vessel. Micro-computed X-ray tomography (XμCT) and histology can elucidate the arrangement of these particles after application. XμCT-analysis has been performed on arterial sections after MDT in order to determine the distribution of the nanoparticles. These measurements have been carried out with a cone X-ray source and corresponding histological sections were stained with Prussian blue. It could be shown that combining XμCT and histology offers the opportunity for a better understanding of the mechanisms of nanoparticle deposition in the vascular system after MDT.

摘要

为了增加肿瘤区域内抗肿瘤药物的剂量,开发了磁药物靶向(MDT)的概念。由氧化铁和生物相容性覆盖层组成的磁性纳米粒子悬浮在水溶液中(磁流体),用作化学治疗剂的载体,在动脉内应用于所需的体腔(即肿瘤)后,通过外部磁场富集。我们建立了一个体外模型来模拟由通过完整牛动脉的磁性氧化铁纳米粒子组成的循环系统中的体内条件,并通过外部磁场将其聚焦,以研究它们在血管中的分布。微计算机断层扫描(XμCT)和组织学可以阐明应用后这些粒子的排列。为了确定纳米粒子的分布,对 MDT 后的动脉切片进行了 XμCT 分析。这些测量是使用锥形 X 射线源进行的,相应的组织学切片用普鲁士蓝染色。结果表明,结合 XμCT 和组织学为更好地了解 MDT 后纳米粒子在血管系统中的沉积机制提供了机会。

相似文献

1
Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology.使用 XμCT 和组织学对血管组织中的超顺磁纳米粒子进行可视化。
Histochem Cell Biol. 2011 Feb;135(2):153-8. doi: 10.1007/s00418-011-0780-8. Epub 2011 Jan 29.
2
Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.股动脉给药后超顺磁性氧化铁纳米颗粒的磁靶向及生物相容性评估
J Biomed Mater Res A. 2008 Mar 1;84(3):598-606. doi: 10.1002/jbm.a.31346.
3
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.动脉内输注和磁性药物靶向治疗后用于局部化疗的超顺磁性纳米颗粒的递送
Anticancer Res. 2007 Jul-Aug;27(4A):2019-22.
4
Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting.通过磁弛豫测量法定量分析磁性纳米颗粒,并与磁性药物靶向治疗后的组织学结果进行比较。
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3222-5. doi: 10.1166/jnn.2006.477.
5
Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.体外磁靶向给药后动脉模型中磁性纳米颗粒的磁弛豫定量分析
Phys Med Biol. 2009 Sep 21;54(18):N417-24. doi: 10.1088/0031-9155/54/18/N03. Epub 2009 Aug 21.
6
Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging.用于潜在的同时磁靶向和肿瘤成像应用的阿拉伯胶包覆磁性纳米粒子。
AAPS J. 2009 Dec;11(4):693-9. doi: 10.1208/s12248-009-9151-y. Epub 2009 Oct 20.
7
Prussian Blue Staining to Visualize Iron Oxide Nanoparticles.普鲁士蓝染色法用于观察氧化铁纳米颗粒。
Methods Mol Biol. 2023;2566:321-332. doi: 10.1007/978-1-0716-2675-7_26.
8
Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting.用于植入辅助磁靶向给药的离体猪心脏心室灌注模型。
Int J Pharm. 2008 Sep 1;361(1-2):202-8. doi: 10.1016/j.ijpharm.2008.05.027. Epub 2008 Jun 23.
9
Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.普鲁士蓝衍生的纳米多孔氧化铁作为用于磁导向化疗的抗癌药物载体
Chem Asian J. 2015 Jul;10(7):1457-62. doi: 10.1002/asia.201500232. Epub 2015 Jun 11.
10
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?用于心血管诊断和治疗药物递送的氧化铁纳米颗粒的远程磁靶向:我们目前进展如何?
Int J Nanomedicine. 2016 Jul 15;11:3191-203. doi: 10.2147/IJN.S110542. eCollection 2016.

引用本文的文献

1
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.用磁性纳米颗粒加载CAR-T细胞以实现可控靶向,可抑制炎性细胞因子释放并改变肿瘤细胞死亡机制。
MedComm (2020). 2025 Jan 5;6(1):e70039. doi: 10.1002/mco2.70039. eCollection 2025 Jan.
2
Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality.负载超顺磁性氧化铁纳米颗粒的人 T 细胞保持抗原特异性 TCR 功能。
Front Immunol. 2023 Aug 17;14:1223695. doi: 10.3389/fimmu.2023.1223695. eCollection 2023.
3
Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.

本文引用的文献

1
Microcomputed tomography analysis of ferrofluids used for cancer treatment.用于癌症治疗的铁磁流体的微型计算机断层扫描分析
J Phys Condens Matter. 2008 May 21;20(20):204152. doi: 10.1088/0953-8984/20/20/204152. Epub 2008 May 1.
2
Targeting cancer cells: magnetic nanoparticles as drug carriers.靶向癌细胞:作为药物载体的磁性纳米颗粒
Eur Biophys J. 2006 May;35(5):446-50. doi: 10.1007/s00249-006-0042-1. Epub 2006 Jan 31.
3
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
米托蒽醌和负载米托蒽醌的氧化铁纳米颗粒诱导人胰腺导管腺癌细胞球发生细胞死亡。
Materials (Basel). 2023 Apr 6;16(7):2906. doi: 10.3390/ma16072906.
4
Cellular SPION Uptake and Toxicity in Various Head and Neck Cancer Cell Lines.不同头颈癌细胞系中细胞对超顺磁性氧化铁纳米颗粒的摄取及毒性
Nanomaterials (Basel). 2021 Mar 13;11(3):726. doi: 10.3390/nano11030726.
5
Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.紫杉醇负载氧化铁纳米颗粒对不同 2D 和 3D 细胞培养模型乳腺癌的细胞作用。
Int J Nanomedicine. 2018 Dec 21;14:161-180. doi: 10.2147/IJN.S187886. eCollection 2019.
6
Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles.载药超顺磁性氧化铁纳米颗粒递送至动脉粥样硬化斑块。
Int J Nanomedicine. 2018 Dec 11;13:8443-8460. doi: 10.2147/IJN.S179273. eCollection 2018.
7
Inner ear barriers to nanomedicine-augmented drug delivery and imaging.纳米医学增强药物递送与成像的内耳屏障
J Otol. 2016 Dec;11(4):165-177. doi: 10.1016/j.joto.2016.11.002. Epub 2016 Nov 25.
8
Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.基于体外细胞毒性和细胞摄取筛选用于乳腺癌治疗的潜在氧化铁纳米颗粒。
Int J Nanomedicine. 2017 Apr 19;12:3207-3220. doi: 10.2147/IJN.S132369. eCollection 2017.
9
Impact of Superparamagnetic Iron Oxide Nanoparticles on Vocal Fold Fibroblasts: Cell Behavior and Cellular Iron Kinetics.超顺磁性氧化铁纳米颗粒对声带成纤维细胞的影响:细胞行为和细胞铁动力学
Nanoscale Res Lett. 2017 Dec;12(1):284. doi: 10.1186/s11671-017-2045-5. Epub 2017 Apr 20.
10
A novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions.一种新型的人动脉模型,用于评估 SPIONs 在流动条件下的磁积累。
Sci Rep. 2017 Feb 8;7:42314. doi: 10.1038/srep42314.
磁靶向给药——局部癌症治疗后磁性载体与化疗药物米托蒽醌的生物分布
J Drug Target. 2003 Apr;11(3):139-49. doi: 10.1080/1061186031000150791.
4
Locoregional cancer treatment with magnetic drug targeting.磁靶向药物进行局部区域癌症治疗
Cancer Res. 2000 Dec 1;60(23):6641-8.
5
Drug targeting.药物靶向
Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S81-91. doi: 10.1016/s0928-0987(00)00166-4.
6
MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.使用氧化铁颗粒的磁共振淋巴造影。VX2兔肿瘤模型中淋巴结转移的检测。
Acta Radiol. 1993 Jan;34(1):10-5.
7
Pharmacologic rationale for regional drug delivery.区域给药的药理学原理。
J Clin Oncol. 1984 May;2(5):498-504. doi: 10.1200/JCO.1984.2.5.498.